Compile Data Set for Download or QSAR
maximum 50k data
Found 58 Enz. Inhib. hit(s) with all data for entry = 155
TargetCannabinoid receptor 2(Homo sapiens (Human))
Allergan

US Patent
LigandPNGBDBM163042(US9062004, 5 | US9670216, 13 4-Bromo-5-propylamino...)
Affinity DataIC50:  4.80nMT: 2°CAssay Description:Plasma membranes prepared from HEK 293 EBNA cells transfected with human CB1 or CB2 cannabinoid receptors (3.7 or 3.3 pmol/mg protein, receptor conce...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCannabinoid receptor 2(Homo sapiens (Human))
Allergan

US Patent
LigandPNGBDBM163042(US9062004, 5 | US9670216, 13 4-Bromo-5-propylamino...)
Affinity DataIC50:  5.40nMT: 2°CAssay Description:Plasma membranes prepared from HEK 293 EBNA cells transfected with human CB1 or CB2 cannabinoid receptors (3.7 or 3.3 pmol/mg protein, receptor conce...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCannabinoid receptor 2(Homo sapiens (Human))
Allergan

US Patent
LigandPNGBDBM163069(US9062004, 36 | US9670216, 36 1-(2-Morpholin-4-yle...)
Affinity DataIC50:  8.5nMT: 2°CAssay Description:Plasma membranes prepared from HEK 293 EBNA cells transfected with human CB1 or CB2 cannabinoid receptors (3.7 or 3.3 pmol/mg protein, receptor conce...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCannabinoid receptor 2(Homo sapiens (Human))
Allergan

US Patent
LigandPNGBDBM163041(US9062004, 4 | US9670216, 4 4-Chloro-5-dimethylami...)
Affinity DataIC50:  17nMT: 2°CAssay Description:Plasma membranes prepared from HEK 293 EBNA cells transfected with human CB1 or CB2 cannabinoid receptors (3.7 or 3.3 pmol/mg protein, receptor conce...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCannabinoid receptor 2(Homo sapiens (Human))
Allergan

US Patent
LigandPNGBDBM163067(US9062004, 34 | US9670216, 34 1-Propyl-5-(3,3,5,5-...)
Affinity DataIC50:  17nMT: 2°CAssay Description:Plasma membranes prepared from HEK 293 EBNA cells transfected with human CB1 or CB2 cannabinoid receptors (3.7 or 3.3 pmol/mg protein, receptor conce...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCannabinoid receptor 2(Homo sapiens (Human))
Allergan

US Patent
LigandPNGBDBM163065(US9062004, 31 | US9670216, 32 4-Chloro-5-(2-diethy...)
Affinity DataIC50:  20nMT: 2°CAssay Description:Plasma membranes prepared from HEK 293 EBNA cells transfected with human CB1 or CB2 cannabinoid receptors (3.7 or 3.3 pmol/mg protein, receptor conce...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCannabinoid receptor 2(Homo sapiens (Human))
Allergan

US Patent
LigandPNGBDBM163051(US9062004, 15 | US9670216, 16 4-Chloro-2-(3,5-dime...)
Affinity DataIC50:  22nMT: 2°CAssay Description:Plasma membranes prepared from HEK 293 EBNA cells transfected with human CB1 or CB2 cannabinoid receptors (3.7 or 3.3 pmol/mg protein, receptor conce...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCannabinoid receptor 2(Homo sapiens (Human))
Allergan

US Patent
LigandPNGBDBM50005908(CHEMBL3234707 | US9062004, 14 | US9670216, 14 4-Br...)
Affinity DataIC50:  42nMT: 2°CAssay Description:Plasma membranes prepared from HEK 293 EBNA cells transfected with human CB1 or CB2 cannabinoid receptors (3.7 or 3.3 pmol/mg protein, receptor conce...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCannabinoid receptor 2(Homo sapiens (Human))
Allergan

US Patent
LigandPNGBDBM163045(US9062004, 8 | US9670216, 8 5-Propylamino-2-(3,3,5...)
Affinity DataIC50:  68nMT: 2°CAssay Description:Plasma membranes prepared from HEK 293 EBNA cells transfected with human CB1 or CB2 cannabinoid receptors (3.7 or 3.3 pmol/mg protein, receptor conce...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCannabinoid receptor 2(Homo sapiens (Human))
Allergan

US Patent
LigandPNGBDBM163048(US9062004, 11 | US9670216, 11 4-Chloro-5-(2-morpho...)
Affinity DataIC50:  83nMT: 2°CAssay Description:Plasma membranes prepared from HEK 293 EBNA cells transfected with human CB1 or CB2 cannabinoid receptors (3.7 or 3.3 pmol/mg protein, receptor conce...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCannabinoid receptor 2(Homo sapiens (Human))
Allergan

US Patent
LigandPNGBDBM163071(US9062004, 38 | US9670216, 38 1-(2-Dimethylaminoet...)
Affinity DataIC50:  105nMT: 2°CAssay Description:Plasma membranes prepared from HEK 293 EBNA cells transfected with human CB1 or CB2 cannabinoid receptors (3.7 or 3.3 pmol/mg protein, receptor conce...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCannabinoid receptor 1(Homo sapiens (Human))
Allergan

US Patent
LigandPNGBDBM163042(US9062004, 5 | US9670216, 13 4-Bromo-5-propylamino...)
Affinity DataIC50:  174nMT: 2°CAssay Description:Plasma membranes prepared from HEK 293 EBNA cells transfected with human CB1 or CB2 cannabinoid receptors (3.7 or 3.3 pmol/mg protein, receptor conce...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCannabinoid receptor 2(Homo sapiens (Human))
Allergan

US Patent
LigandPNGBDBM163049(US9062004, 12 | US9670216, 12 4-Chloro-5-(2-dimeth...)
Affinity DataIC50:  204nMT: 2°CAssay Description:Plasma membranes prepared from HEK 293 EBNA cells transfected with human CB1 or CB2 cannabinoid receptors (3.7 or 3.3 pmol/mg protein, receptor conce...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCannabinoid receptor 1(Homo sapiens (Human))
Allergan

US Patent
LigandPNGBDBM163069(US9062004, 36 | US9670216, 36 1-(2-Morpholin-4-yle...)
Affinity DataIC50:  219nMT: 2°CAssay Description:Plasma membranes prepared from HEK 293 EBNA cells transfected with human CB1 or CB2 cannabinoid receptors (3.7 or 3.3 pmol/mg protein, receptor conce...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCannabinoid receptor 2(Homo sapiens (Human))
Allergan

US Patent
LigandPNGBDBM163068(US9062004, 35 | US9670216, 35 2-Propyl-5-(3,3,5,5-...)
Affinity DataIC50:  240nMT: 2°CAssay Description:Plasma membranes prepared from HEK 293 EBNA cells transfected with human CB1 or CB2 cannabinoid receptors (3.7 or 3.3 pmol/mg protein, receptor conce...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCannabinoid receptor 1(Homo sapiens (Human))
Allergan

US Patent
LigandPNGBDBM163067(US9062004, 34 | US9670216, 34 1-Propyl-5-(3,3,5,5-...)
Affinity DataIC50:  257nMT: 2°CAssay Description:Plasma membranes prepared from HEK 293 EBNA cells transfected with human CB1 or CB2 cannabinoid receptors (3.7 or 3.3 pmol/mg protein, receptor conce...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCannabinoid receptor 2(Homo sapiens (Human))
Allergan

US Patent
LigandPNGBDBM163040(US9062004, 3 | US9670216, 3 4-Chloro-5-methylamino...)
Affinity DataIC50:  355nMT: 2°CAssay Description:Plasma membranes prepared from HEK 293 EBNA cells transfected with human CB1 or CB2 cannabinoid receptors (3.7 or 3.3 pmol/mg protein, receptor conce...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCannabinoid receptor 2(Homo sapiens (Human))
Allergan

US Patent
LigandPNGBDBM163044(US9062004, 7 | US9670216, 7 5-Dimethylamino-2-(3,3...)
Affinity DataIC50:  380nMT: 2°CAssay Description:Plasma membranes prepared from HEK 293 EBNA cells transfected with human CB1 or CB2 cannabinoid receptors (3.7 or 3.3 pmol/mg protein, receptor conce...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCannabinoid receptor 2(Homo sapiens (Human))
Allergan

US Patent
LigandPNGBDBM163039(US9062004, 2 | US9670216, 2 4,5-Dichloro-2-(3,3,5,...)
Affinity DataIC50:  389nMT: 2°CAssay Description:Plasma membranes prepared from HEK 293 EBNA cells transfected with human CB1 or CB2 cannabinoid receptors (3.7 or 3.3 pmol/mg protein, receptor conce...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCannabinoid receptor 1(Homo sapiens (Human))
Allergan

US Patent
LigandPNGBDBM163042(US9062004, 5 | US9670216, 13 4-Bromo-5-propylamino...)
Affinity DataIC50:  1.02E+3nMT: 2°CAssay Description:Plasma membranes prepared from HEK 293 EBNA cells transfected with human CB1 or CB2 cannabinoid receptors (3.7 or 3.3 pmol/mg protein, receptor conce...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCannabinoid receptor 1(Homo sapiens (Human))
Allergan

US Patent
LigandPNGBDBM163041(US9062004, 4 | US9670216, 4 4-Chloro-5-dimethylami...)
Affinity DataIC50:  1.02E+3nMT: 2°CAssay Description:Plasma membranes prepared from HEK 293 EBNA cells transfected with human CB1 or CB2 cannabinoid receptors (3.7 or 3.3 pmol/mg protein, receptor conce...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCannabinoid receptor 2(Homo sapiens (Human))
Allergan

US Patent
LigandPNGBDBM163065(US9062004, 31 | US9670216, 32 4-Chloro-5-(2-diethy...)
Affinity DataIC50:  1.29E+3nMT: 2°CAssay Description:Plasma membranes prepared from HEK 293 EBNA cells transfected with human CB1 or CB2 cannabinoid receptors (3.7 or 3.3 pmol/mg protein, receptor conce...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCannabinoid receptor 2(Homo sapiens (Human))
Allergan

US Patent
LigandPNGBDBM163070(US9062004, 37 | US9670216, 37 2-(2-Morpholin-4-yle...)
Affinity DataIC50:  1.51E+3nMT: 2°CAssay Description:Plasma membranes prepared from HEK 293 EBNA cells transfected with human CB1 or CB2 cannabinoid receptors (3.7 or 3.3 pmol/mg protein, receptor conce...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCannabinoid receptor 2(Homo sapiens (Human))
Allergan

US Patent
LigandPNGBDBM163038(US9062004, 1 | US9670216, 13 5-hydroxy-2-(3,3,5,5-...)
Affinity DataIC50:  1.82E+3nMT: 2°CAssay Description:Plasma membranes prepared from HEK 293 EBNA cells transfected with human CB1 or CB2 cannabinoid receptors (3.7 or 3.3 pmol/mg protein, receptor conce...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCannabinoid receptor 1(Homo sapiens (Human))
Allergan

US Patent
LigandPNGBDBM163051(US9062004, 15 | US9670216, 16 4-Chloro-2-(3,5-dime...)
Affinity DataIC50:  1.86E+3nMT: 2°CAssay Description:Plasma membranes prepared from HEK 293 EBNA cells transfected with human CB1 or CB2 cannabinoid receptors (3.7 or 3.3 pmol/mg protein, receptor conce...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCannabinoid receptor 2(Homo sapiens (Human))
Allergan

US Patent
LigandPNGBDBM163072(US9062004, 39 | US9670216, 39 2-(2-Dimethylaminoet...)
Affinity DataIC50:  2.04E+3nMT: 2°CAssay Description:Plasma membranes prepared from HEK 293 EBNA cells transfected with human CB1 or CB2 cannabinoid receptors (3.7 or 3.3 pmol/mg protein, receptor conce...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCannabinoid receptor 2(Homo sapiens (Human))
Allergan

US Patent
LigandPNGBDBM163043(US9062004, 6 | US9670216, 6 5-Methylamino-2-(3,3,5...)
Affinity DataIC50:  2.09E+3nMT: 2°CAssay Description:Plasma membranes prepared from HEK 293 EBNA cells transfected with human CB1 or CB2 cannabinoid receptors (3.7 or 3.3 pmol/mg protein, receptor conce...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCannabinoid receptor 1(Homo sapiens (Human))
Allergan

US Patent
LigandPNGBDBM163065(US9062004, 31 | US9670216, 32 4-Chloro-5-(2-diethy...)
Affinity DataIC50:  2.63E+3nMT: 2°CAssay Description:Plasma membranes prepared from HEK 293 EBNA cells transfected with human CB1 or CB2 cannabinoid receptors (3.7 or 3.3 pmol/mg protein, receptor conce...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCannabinoid receptor 1(Homo sapiens (Human))
Allergan

US Patent
LigandPNGBDBM163071(US9062004, 38 | US9670216, 38 1-(2-Dimethylaminoet...)
Affinity DataIC50:  3.98E+3nMT: 2°CAssay Description:Plasma membranes prepared from HEK 293 EBNA cells transfected with human CB1 or CB2 cannabinoid receptors (3.7 or 3.3 pmol/mg protein, receptor conce...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCannabinoid receptor 1(Homo sapiens (Human))
Allergan

US Patent
LigandPNGBDBM163048(US9062004, 11 | US9670216, 11 4-Chloro-5-(2-morpho...)
Affinity DataIC50:  3.98E+3nMT: 2°CAssay Description:Plasma membranes prepared from HEK 293 EBNA cells transfected with human CB1 or CB2 cannabinoid receptors (3.7 or 3.3 pmol/mg protein, receptor conce...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCannabinoid receptor 1(Homo sapiens (Human))
Allergan

US Patent
LigandPNGBDBM50005908(CHEMBL3234707 | US9062004, 14 | US9670216, 14 4-Br...)
Affinity DataIC50:  7.41E+3nMT: 2°CAssay Description:Plasma membranes prepared from HEK 293 EBNA cells transfected with human CB1 or CB2 cannabinoid receptors (3.7 or 3.3 pmol/mg protein, receptor conce...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCannabinoid receptor 2(Homo sapiens (Human))
Allergan

US Patent
LigandPNGBDBM163055(US9062004, 20 | US9670216, 20 2-(3,5-Bistrifluorom...)
Affinity DataIC50: >1.00E+4nMT: 2°CAssay Description:Plasma membranes prepared from HEK 293 EBNA cells transfected with human CB1 or CB2 cannabinoid receptors (3.7 or 3.3 pmol/mg protein, receptor conce...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCannabinoid receptor 2(Homo sapiens (Human))
Allergan

US Patent
LigandPNGBDBM163056(US9062004, 21 | US9670216, 21 2-(3,5-Bistrifluorom...)
Affinity DataIC50: >1.00E+4nMT: 2°CAssay Description:Plasma membranes prepared from HEK 293 EBNA cells transfected with human CB1 or CB2 cannabinoid receptors (3.7 or 3.3 pmol/mg protein, receptor conce...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCannabinoid receptor 2(Homo sapiens (Human))
Allergan

US Patent
LigandPNGBDBM196285(US9670216, 22 2-(3,5-Bistrifluoromethylphenyl)-4-c...)
Affinity DataIC50: >1.00E+4nMT: 2°CAssay Description:Plasma membranes prepared from HEK 293 EBNA cells transfected with human CB1 or CB2 cannabinoid receptors (3.7 or 3.3 pmol/mg protein, receptor conce...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCannabinoid receptor 2(Homo sapiens (Human))
Allergan

US Patent
LigandPNGBDBM163058(US9062004, 24 | US9670216, 24 2-t-Butyl-4-chloro--...)
Affinity DataIC50: >1.00E+4nMT: 2°CAssay Description:Plasma membranes prepared from HEK 293 EBNA cells transfected with human CB1 or CB2 cannabinoid receptors (3.7 or 3.3 pmol/mg protein, receptor conce...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCannabinoid receptor 1(Homo sapiens (Human))
Allergan

US Patent
LigandPNGBDBM196289(US9670216, 25 4-Chloro-2-(3,5-dichlorophenyl)-5-pr...)
Affinity DataIC50: >1.00E+4nMT: 2°CAssay Description:Plasma membranes prepared from HEK 293 EBNA cells transfected with human CB1 or CB2 cannabinoid receptors (3.7 or 3.3 pmol/mg protein, receptor conce...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCannabinoid receptor 2(Homo sapiens (Human))
Allergan

US Patent
LigandPNGBDBM196289(US9670216, 25 4-Chloro-2-(3,5-dichlorophenyl)-5-pr...)
Affinity DataIC50: >1.00E+4nMT: 2°CAssay Description:Plasma membranes prepared from HEK 293 EBNA cells transfected with human CB1 or CB2 cannabinoid receptors (3.7 or 3.3 pmol/mg protein, receptor conce...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCannabinoid receptor 2(Homo sapiens (Human))
Allergan

US Patent
LigandPNGBDBM163060(US9062004, 26 | US9670216, 26 4-Chloro-2-(2,5-dime...)
Affinity DataIC50:  1.00E+4nMT: 2°CAssay Description:Plasma membranes prepared from HEK 293 EBNA cells transfected with human CB1 or CB2 cannabinoid receptors (3.7 or 3.3 pmol/mg protein, receptor conce...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCannabinoid receptor 2(Homo sapiens (Human))
Allergan

US Patent
LigandPNGBDBM163061(US9062004, 27 | US9670216, 27 2-t-Butyl-4-chloro-5...)
Affinity DataIC50: >1.00E+4nMT: 2°CAssay Description:Plasma membranes prepared from HEK 293 EBNA cells transfected with human CB1 or CB2 cannabinoid receptors (3.7 or 3.3 pmol/mg protein, receptor conce...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCannabinoid receptor 2(Homo sapiens (Human))
Allergan

US Patent
LigandPNGBDBM163062(US9062004, 28 | US9670216, 28 4-Chloro-2-(3,5-dich...)
Affinity DataIC50: >1.00E+4nMT: 2°CAssay Description:Plasma membranes prepared from HEK 293 EBNA cells transfected with human CB1 or CB2 cannabinoid receptors (3.7 or 3.3 pmol/mg protein, receptor conce...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCannabinoid receptor 2(Homo sapiens (Human))
Allergan

US Patent
LigandPNGBDBM163063(US9062004, 29 | US9670216, 29 4-Chloro-2-(2,5-dime...)
Affinity DataIC50: >1.00E+4nMT: 2°CAssay Description:Plasma membranes prepared from HEK 293 EBNA cells transfected with human CB1 or CB2 cannabinoid receptors (3.7 or 3.3 pmol/mg protein, receptor conce...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCannabinoid receptor 2(Homo sapiens (Human))
Allergan

US Patent
LigandPNGBDBM163064(US9062004, 30 | US9670216, 30 2-Benzyl-4-chloro-5-...)
Affinity DataIC50: >1.00E+4nMT: 2°CAssay Description:Plasma membranes prepared from HEK 293 EBNA cells transfected with human CB1 or CB2 cannabinoid receptors (3.7 or 3.3 pmol/mg protein, receptor conce...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCannabinoid receptor 1(Homo sapiens (Human))
Allergan

US Patent
LigandPNGBDBM163049(US9062004, 12 | US9670216, 12 4-Chloro-5-(2-dimeth...)
Affinity DataIC50: >1.00E+4nMT: 2°CAssay Description:Plasma membranes prepared from HEK 293 EBNA cells transfected with human CB1 or CB2 cannabinoid receptors (3.7 or 3.3 pmol/mg protein, receptor conce...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCannabinoid receptor 2(Homo sapiens (Human))
Allergan

US Patent
LigandPNGBDBM163047(US9062004, 10 | US9670216, 10 4-Chloro-2-cyclohexy...)
Affinity DataIC50:  1.00E+4nMT: 2°CAssay Description:Plasma membranes prepared from HEK 293 EBNA cells transfected with human CB1 or CB2 cannabinoid receptors (3.7 or 3.3 pmol/mg protein, receptor conce...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCannabinoid receptor 2(Homo sapiens (Human))
Allergan

US Patent
LigandPNGBDBM163046(US9062004, 9 | US9670216, 9 4-Chloro-2-phenyl-5-pr...)
Affinity DataIC50: >1.00E+4nMT: 2°CAssay Description:Plasma membranes prepared from HEK 293 EBNA cells transfected with human CB1 or CB2 cannabinoid receptors (3.7 or 3.3 pmol/mg protein, receptor conce...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCannabinoid receptor 1(Homo sapiens (Human))
Allergan

US Patent
LigandPNGBDBM163068(US9062004, 35 | US9670216, 35 2-Propyl-5-(3,3,5,5-...)
Affinity DataIC50: >1.00E+4nMT: 2°CAssay Description:Plasma membranes prepared from HEK 293 EBNA cells transfected with human CB1 or CB2 cannabinoid receptors (3.7 or 3.3 pmol/mg protein, receptor conce...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCannabinoid receptor 1(Homo sapiens (Human))
Allergan

US Patent
LigandPNGBDBM163045(US9062004, 8 | US9670216, 8 5-Propylamino-2-(3,3,5...)
Affinity DataIC50: >1.00E+4nMT: 2°CAssay Description:Plasma membranes prepared from HEK 293 EBNA cells transfected with human CB1 or CB2 cannabinoid receptors (3.7 or 3.3 pmol/mg protein, receptor conce...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCannabinoid receptor 1(Homo sapiens (Human))
Allergan

US Patent
LigandPNGBDBM163044(US9062004, 7 | US9670216, 7 5-Dimethylamino-2-(3,3...)
Affinity DataIC50: >1.00E+4nMT: 2°CAssay Description:Plasma membranes prepared from HEK 293 EBNA cells transfected with human CB1 or CB2 cannabinoid receptors (3.7 or 3.3 pmol/mg protein, receptor conce...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCannabinoid receptor 1(Homo sapiens (Human))
Allergan

US Patent
LigandPNGBDBM163070(US9062004, 37 | US9670216, 37 2-(2-Morpholin-4-yle...)
Affinity DataIC50: >1.00E+4nMT: 2°CAssay Description:Plasma membranes prepared from HEK 293 EBNA cells transfected with human CB1 or CB2 cannabinoid receptors (3.7 or 3.3 pmol/mg protein, receptor conce...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCannabinoid receptor 1(Homo sapiens (Human))
Allergan

US Patent
LigandPNGBDBM163043(US9062004, 6 | US9670216, 6 5-Methylamino-2-(3,3,5...)
Affinity DataIC50: >1.00E+4nMT: 2°CAssay Description:Plasma membranes prepared from HEK 293 EBNA cells transfected with human CB1 or CB2 cannabinoid receptors (3.7 or 3.3 pmol/mg protein, receptor conce...More data for this Ligand-Target Pair
In DepthDetails US Patent
Displayed 1 to 50 (of 58 total ) | Next | Last >>
Jump to: